New azole antifungals.: 2.: Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol

被引:44
作者
Bartroli, J [1 ]
Turmo, E [1 ]
Alguero, M [1 ]
Boncompte, E [1 ]
Vericat, ML [1 ]
Conte, L [1 ]
Ramis, J [1 ]
Merlos, M [1 ]
García-Rafanell, J [1 ]
Forn, J [1 ]
机构
[1] J Uriach & Cia SA, Res Ctr, E-08026 Barcelona, Spain
关键词
D O I
10.1021/jm970726e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 92 azole antifungals containing an amido alcohol unit was synthesized. The nature and substitution of the amide portion was systematically modified in search of improved antifungal activity, especially against filamentous fungi. The compounds were tested in vitro against a variety of clinically important pathogens and in vivo (po) in a murine candidosis model. Thiazole and thiophene carboxamides carrying both a substituted phenyl ring and a small alkyl. group were best suited for activity against filamentous fungi. In a subset of these compounds, the amide portion was conformationally locked by means of a pyrimidone ring and it was proven that only an orthogonal orientation of the phenyl ring yields bioactive products. A tendency to display long plasma elimination half-lives was observed in both series. Two compounds, 74 and 107, representative of the open and cyclic amides, respectively, were chosen for further studies, based on their excellent activity in in vivo murine models of candidosis and aspergillosis. This work describes the SARs found within this series. The next paper displays the results obtained in a related series of compounds, the quinazolinones.
引用
收藏
页码:1855 / 1868
页数:14
相关论文
共 44 条
[31]  
PLOUVIER B, 1991, HETEROCYCLES, V32, P693
[32]  
RESTREPO M, 1995, 35 INT C ANT AG CHEM
[33]  
REX JH, 1995, ANTIMICROB AGENTS CH, V39, P1, DOI 10.1128/AAC.39.1.1
[34]  
Richardson K, 1983, US Patent, Patent No. 4404216
[35]  
SHCMIDT P, 1959, HELV CHIM ACTA, V1, P349
[36]   A NEW SYNTHETIC METHOD OF ALKYL CARBONOCYANIDATE N-OXIDES [J].
SHIMIZU, T ;
HAYASHI, Y ;
TERAMURA, K .
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1985, 58 (09) :2519-2522
[37]  
STEVENS DA, 35 INT C ANT AG CHEM
[38]  
Tasaka A, 1997, CHEM PHARM BULL, V45, P321, DOI 10.1248/cpb.45.321
[39]  
TASAKA A, 1993, CHEM PHARM BULL, V41, P1035, DOI 10.1248/cpb.41.1035
[40]  
Turner WW, 1996, CURR PHARM DESIGN, V2, P209